Join to View Full Profile
3959 BroadwayNew York, NY 10032
Phone+1 212-305-5437
Fax+1 212-342-2293
Dr. Geneslaw is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Critical Care Medicine, 2016 - 2019- New York Presbyterian Hospital (Columbia Campus)Chief Residency, Pediatrics, 2015 - 2016
- New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2012 - 2015
Tufts University School of MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2014 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Critical Care Medicine
Publications & Presentations
PubMed
- Correction: Delirium in Children Hospitalized with Acute COVID-19 or MIS-C: Secondary Analysis of the 2020-2021 Global Consortium Study of Neurologic Dysfunction in CO...Neelima K Marupudi, Diana Paola Escobar-Serna, Leslie Dervan, Anna Janas, Andrew S Geneslaw
Neurocritical Care. 2026-05-05 - Delirium in Children Hospitalized with Acute COVID-19 or MIS-C: Secondary Analysis of the 2020-2021 Global Consortium Study of Neurologic Dysfunction in COVID-19.Neelima K Marupudi, Diana Paola Escobar-Serna, Leslie Dervan, Anna Janas, Andrew S Geneslaw
Neurocritical Care. 2026-04-06 - Pulse rate variability as a predictor for length of stay for patients with bronchiolitis in the pediatric intensive care unit.Soon Bin Kwon, Bennett Weinerman, Daniel Nametz, Tammam Alalqum, Isaac S Lee
Journal of Clinical Monitoring and Computing. 2025-06-01
Press Mentions
Columbia Pediatrics Researchers Receive Seed Funding for Innovative ResearchFebruary 20th, 2020
Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and RationaleMay 29th, 2020
A Step in De-MIS-Tifying MIS-C: The Importance of Early Immunomodulatory Therapy in MIS-CAugust 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
